Ola Blixt, University of Copenhagen (IMAGE)
Caption
The world's most widespread test for ovarian cancer reports false-positives in 94 of 100 diagnosed cases. Adding a test for a certain sugar molecule could reduce the number of mistaken diagnosis by at least 50 percent finds Copenhagen Chemist Ola Blixt.
Credit
Foto: Jes Andersen/University of Copenhagen
Usage Restrictions
None
License
Licensed content